×

ENTER REPORT NAME TO SEARCH

Global Spatial Genomics In-Depth Monitoring and Development Analysis Report 2023

Report ID: ARS10112 | Category: Healthcare | Pages: 113 | Format: PDF | Published Date: December 18,2023


Table of Contents

Table of Content

1 Spatial Genomics Market Introduction and Overview
1.1 Spatial Genomics Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Spatial Genomics Market Size & Forecast (2018-2029)
2.2 Spatial Genomics Growth Trends Analysis by Regions
2.2.1 Spatial Genomics Market Size by Regions: 2018 VS 2023 VS 2029
2.2.2 Spatial Genomics Historic Market Size by Regions (2018-2023)
2.2.3 Spatial Genomics Forecasted Market Size by Regions (2023-2029)
2.2.4 North America Spatial Genomics Market Size & Forecast (2018-2029)
2.2.5 Europe Spatial Genomics Market Size & Forecast (2018-2029)
2.2.6 Asia-Pacific Spatial Genomics Market Size & Forecast (2018-2029)
2.2.7 Latin America Spatial Genomics Market Size & Forecast (2018-2029)
2.2.8 Middle East & Africa Spatial Genomics Market Size & Forecast (2018-2029)
3 North America
3.1 North America Spatial Genomics Revenue by Countries
3.1.1 North America Spatial Genomics Revenue by Countries (2018-2029)
3.2 North America Spatial Genomics Revenue by Players
3.3 North America Spatial Genomics Revenue by Types
3.4 North America Spatial Genomics Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Spatial Genomics Revenue by Countries
4.1.1 Asia Pacific Spatial Genomics Revenue by Countries (2018-2029)
4.2 Asia Pacific Spatial Genomics Revenue by Players
4.3 Asia Pacific Spatial Genomics Revenue by Types
4.4 Asia Pacific Spatial Genomics Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Spatial Genomics Revenue by Countries
5.1.1 Europe Spatial Genomics Revenue by Countries (2018-2029)
5.2 Europe Spatial Genomics Revenue by Players
5.3 Europe Spatial Genomics Revenue by Types
5.4 Europe Spatial Genomics Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Spatial Genomics Revenue by Countries
6.1.1 Latin America Spatial Genomics Revenue by Countries (2018-2029)
6.2 Latin America Spatial Genomics Revenue by Players
6.3 Latin America Spatial Genomics Revenue by Types
6.4 Latin America Spatial Genomics Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Spatial Genomics Revenue by Countries
7.1.1 Middle East & Africa Spatial Genomics Revenue by Countries (2018-2029)
7.2 Middle East & Africa Spatial Genomics Revenue by Players
7.3 Middle East & Africa Spatial Genomics Revenue by Types
7.4 Middle East & Africa Spatial Genomics Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Spatial Genomics Historical and Forecast Market Analysis by Type
8.1 Global Spatial Genomics Revenue and Market Share by Type
8.2 Global Spatial Genomics Market Forecast by Type (2023-2029)
9 Global Spatial Genomics Historical and Forecast Market Analysis by Application
9.1 Global Spatial Genomics Revenue Market Share by Application (2018-2023)
9.2 Spatial Genomics Market Forecast by Application (2023-2029)
10 Spatial Genomics Industry Dynamic Analysis
10.1 Spatial Genomics Market Trends Analysis
10.2 Spatial Genomics Market Drivers Analysis
10.3 Spatial Genomics Market Challenges Analysis
10.4 Spatial Genomics Market Restraints Analysis
10.5 Spatial Genomics Industry Mergers & Acquisitions
10.6 Spatial Genomics Industry New Entrants and Expansion Plans
11 Players Profiles
11.1  Thermo Fisher Scientific Inc. (U.S.)
11.1.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
11.1.2 Spatial Genomics Product Overview
11.1.3 Thermo Fisher Scientific Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.1.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
11.2  10X Genomics (U.S.)
11.2.1 10X Genomics (U.S.) Company Profile
11.2.2 Spatial Genomics Product Overview
11.2.3 10X Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.2.4 10X Genomics (U.S.) Business Overview
11.3  NanoString Technologies Inc. (U.S.)
11.3.1 NanoString Technologies Inc. (U.S.) Company Profile
11.3.2 Spatial Genomics Product Overview
11.3.3 NanoString Technologies Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.3.4 NanoString Technologies Inc. (U.S.) Business Overview
11.4  Illumina Inc. (U.S.)
11.4.1 Illumina Inc. (U.S.) Company Profile
11.4.2 Spatial Genomics Product Overview
11.4.3 Illumina Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.4.4 Illumina Inc. (U.S.) Business Overview
11.5  Bio-Rad Laboratories, Inc. (U.S.)
11.5.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
11.5.2 Spatial Genomics Product Overview
11.5.3 Bio-Rad Laboratories, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.5.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
11.6  QIAGEN (Netherlands)
11.6.1 QIAGEN (Netherlands) Company Profile
11.6.2 Spatial Genomics Product Overview
11.6.3 QIAGEN (Netherlands) Spatial Genomics Market Performance (2018-2023)
11.6.4 QIAGEN (Netherlands) Business Overview
11.7  Agilent Technologies, Inc. (U.S.)
11.7.1 Agilent Technologies, Inc. (U.S.) Company Profile
11.7.2 Spatial Genomics Product Overview
11.7.3 Agilent Technologies, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.7.4 Agilent Technologies, Inc. (U.S.) Business Overview
11.8  F. Hoffmann-La Roche Ltd. (Switzerland)
11.8.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
11.8.2 Spatial Genomics Product Overview
11.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.8.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
11.9  S2 Genomics, Inc. (U.S.)
11.9.1 S2 Genomics, Inc. (U.S.) Company Profile
11.9.2 Spatial Genomics Product Overview
11.9.3 S2 Genomics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.9.4 S2 Genomics, Inc. (U.S.) Business Overview
11.10  Seven Bridges Genomics (U.S.)
11.10.1 Seven Bridges Genomics (U.S.) Company Profile
11.10.2 Spatial Genomics Product Overview
11.10.3 Seven Bridges Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.10.4 Seven Bridges Genomics (U.S.) Business Overview
11.11  CARTANA AB (Sweden)
11.11.1 CARTANA AB (Sweden) Company Profile
11.11.2 Spatial Genomics Product Overview
11.11.3 CARTANA AB (Sweden) Spatial Genomics Market Performance (2018-2023)
11.11.4 CARTANA AB (Sweden) Business Overview
11.12  READCOOR, INC (U.S.)
11.12.1 READCOOR, INC (U.S.) Company Profile
11.12.2 Spatial Genomics Product Overview
11.12.3 READCOOR, INC (U.S.) Spatial Genomics Market Performance (2018-2023)
11.12.4 READCOOR, INC (U.S.) Business Overview
11.13  Advanced Cell Diagnostics, Inc. (U.S.)
11.13.1 Advanced Cell Diagnostics, Inc. (U.S.) Company Profile
11.13.2 Spatial Genomics Product Overview
11.13.3 Advanced Cell Diagnostics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.13.4 Advanced Cell Diagnostics, Inc. (U.S.) Business Overview
11.14  Dovetail Genomics (U.S.)
11.14.1 Dovetail Genomics (U.S.) Company Profile
11.14.2 Spatial Genomics Product Overview
11.14.3 Dovetail Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.14.4 Dovetail Genomics (U.S.) Business Overview
11.15  Novartis AG (Switzerland)
11.15.1 Novartis AG (Switzerland) Company Profile
11.15.2 Spatial Genomics Product Overview
11.15.3 Novartis AG (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.15.4 Novartis AG (Switzerland) Business Overview
11.16  Pfizer Inc. (U.S.)
11.16.1 Pfizer Inc. (U.S.) Company Profile
11.16.2 Spatial Genomics Product Overview
11.16.3 Pfizer Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.16.4 Pfizer Inc. (U.S.) Business Overview
11.17  Merck & Co., Inc. (Germany)
11.17.1 Merck & Co., Inc. (Germany) Company Profile
11.17.2 Spatial Genomics Product Overview
11.17.3 Merck & Co., Inc. (Germany) Spatial Genomics Market Performance (2018-2023)
11.17.4 Merck & Co., Inc. (Germany) Business Overview
11.18  Novo Nordisk A/S (Denmark)
11.18.1 Novo Nordisk A/S (Denmark) Company Profile
11.18.2 Spatial Genomics Product Overview
11.18.3 Novo Nordisk A/S (Denmark) Spatial Genomics Market Performance (2018-2023)
11.18.4 Novo Nordisk A/S (Denmark) Business Overview
11.19  Amgen Inc. (U.S.)
11.19.1 Amgen Inc. (U.S.) Company Profile
11.19.2 Spatial Genomics Product Overview
11.19.3 Amgen Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.19.4 Amgen Inc. (U.S.) Business Overview
11.20  Johnson & Johnson Services, Inc. (U.S.)
11.20.1 Johnson & Johnson Services, Inc. (U.S.) Company Profile
11.20.2 Spatial Genomics Product Overview
11.20.3 Johnson & Johnson Services, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.20.4 Johnson & Johnson Services, Inc. (U.S.) Business Overview
11.21  Gsk plc (U.K.)
11.21.1 Gsk plc (U.K.) Company Profile
11.21.2 Spatial Genomics Product Overview
11.21.3 Gsk plc (U.K.) Spatial Genomics Market Performance (2018-2023)
11.21.4 Gsk plc (U.K.) Business Overview
11.22  Bayer AG (Germany)   
11.22.1 Bayer AG (Germany)    Company Profile
11.22.2 Spatial Genomics Product Overview
11.22.3 Bayer AG (Germany)    Spatial Genomics Market Performance (2018-2023)
11.22.4 Bayer AG (Germany)    Business Overview
12 Research Findings and Conclusion

FAQ's

It contains all the geographic trends, and market analysis for global market